TPCHRF - Round 5 - Methotrexate in Seriously Sick Kids (MiSSK); personalised Cancer Treatment using pharmacogenomics to improve patient outcomes and reduce the cost of cancer care when treating seriously sick children

Project Details

StatusFinished
Effective start/end date1/07/1730/04/24

Funding

  • Department of Health (Western Australia): A$236,659.00